Biotron Limited Price (BIT.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

902,170,065

(9.9079)%

Biotron Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.003-0.11
  • Market Cap 6.32M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Dr. Michelle Miller BSc., GCertAppFin, MSc., Ph.D.
  • IPO Date: January, 23, 2001
  • Country: AU
  • Currency: AUD
  • Headquaters: Sydney, NSW
  • Employees: 4

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation